Formulation of Transliposomal Nanocarrier Gel Containing Strychnine for the Effective Management of Skin Cancer
Open Access
Abstract
Strychnine (STCN) has demonstrated an exceptional anticancer effect against various cancers. However, the STCN clinical utility has been hampered by its low water solubility, restricted therapeutic window, short half-life, and significant toxicity. The objective of this investigation was to design and optimize a formulation of strychnine-loaded transliposomes (STCN–TLs) for dermal administration of STCN to treat skin cancer. The formulations of STCN–TL were examined in terms of vesicle size (VS), polydispersity index (PDI), entrapment efficiency (EE), and in vitro delivery. The improved STCN–TL formulation exhibited VS, PDI, EE, and in vitro delivery of 101.5 ± 2.14 nm, 0.218 ± 0.12, 81.74 ± 1.43%, and 85.39 ± 2.33%, respectively. In an ex vivo penetration, the created STCN–TL formulation demonstrated a 2.5-fold increase in permeability compared to the STCN solution. CLSM pictures of skin (rat) revealed that the rhodamine B-loaded transliposome preparation penetrated deeper than the rhodamine B hydroalcoholic mixture. Additionally, rat skin managed with STCN–TL nanogel exhibited a significant increase in Cskin max and AUC0-8 compared to rat skin treated with traditional STCN gel. The findings demonstrated that the transliposome preparation might be a suitable nanocarrier for the cutaneous distribution of STCN in the amelioration of skin cancer.Keywords
Funding Information
- King Saud University, Riyadh, Saudi Arabia (RSPD2023R945)
This publication has 41 references indexed in Scilit:
- Anticarcinogenic effect of brucine in diethylnitrosamine initiated and phenobarbital-promoted hepatocarcinogenesis in ratsChemico-Biological Interactions, 2013
- Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: The role of hypoxia inducible factor 1 pathwayToxicology Letters, 2013
- Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidilInternational Journal of Pharmaceutics, 2009
- Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line – RPMI 8226Food and Chemical Toxicology, 2009
- Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterizationActa Pharmacologica Sinica, 2007
- The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanismJournal of Ethnopharmacology, 2006
- Synthesis applications of cationic aza-Cope rearrangements. 26. Enantioselective total synthesis of (-)-strychnineJournal of the American Chemical Society, 1993
- Processing of nux vomica. II. Changes in alkaloid composition of the seeds of Strychnos nux-vomica on traditional drug-processing.Chemical and Pharmaceutical Bulletin, 1990
- Purification and Properties of Strictosidine Synthase, the Key Enzyme in Indole Alkaloid FormationEuropean Journal of Biochemistry, 1979
- Biosynthesis of strychnineJournal of the Chemical Society, Chemical Communications, 1973